DK1778720T3 - Antimikrobielle peptider omfattende et arginin- og/eller lysinholdigt motiv - Google Patents

Antimikrobielle peptider omfattende et arginin- og/eller lysinholdigt motiv

Info

Publication number: DK1778720T3
Authority: DK; Denmark
Prior art keywords: arginine; lysine; antimicrobial peptides; containing motif; amino acids
Prior art date: 2004-08-18

Application number

DK05778505.7T

Other languages

English (en)

Inventor

Deborah O'neil

Original Assignee

Novabiotics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-18

Filing date

2005-08-18

Publication date

2010-11-29

2004-08-18 Priority claimed from GBGB0418414.9A external-priority patent/GB0418414D0/en

2005-08-18 Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd

2010-11-29 Application granted granted Critical

2010-11-29 Publication of DK1778720T3 publication Critical patent/DK1778720T3/da

Links

102000044503 Antimicrobial Peptides Human genes 0.000 title 1
108700042778 Antimicrobial Peptides Proteins 0.000 title 1
239000004475 Arginine Substances 0.000 title 1
239000004472 Lysine Substances 0.000 title 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
150000001413 amino acids Chemical class 0.000 abstract 3
-1 cationic amino acids Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Virology (AREA)
Zoology (AREA)
Toxicology (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)

DK05778505.7T 2004-08-18 2005-08-18 Antimikrobielle peptider omfattende et arginin- og/eller lysinholdigt motiv DK1778720T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0418414.9A GB0418414D0 (en)	2004-08-18	2004-08-18	Peptide
US7979505A	2005-03-14	2005-03-14
PCT/GB2005/003245 WO2006018652A2 (en)	2004-08-18	2005-08-18	Antimicrobial peptides comprising an arginine- and/or lysine-containing motif

Publications (1)

Publication Number	Publication Date
DK1778720T3 true DK1778720T3 (da)	2010-11-29

Family

ID=35907779

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK05778505.7T DK1778720T3 (da)	2004-08-18	2005-08-18	Antimikrobielle peptider omfattende et arginin- og/eller lysinholdigt motiv
DK08001112.5T DK1927597T3 (da)	2004-08-18	2005-08-18	Antibakterielle peptider

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK08001112.5T DK1927597T3 (da)	2004-08-18	2005-08-18	Antibakterielle peptider

Country Status (25)

Country	Link
US (4)	US7847059B2 (da)
EP (5)	EP1778720B1 (da)
JP (1)	JP5020078B2 (da)
KR (1)	KR101234780B1 (da)
CN (3)	CN101031583B (da)
AT (1)	ATE479704T1 (da)
AU (1)	AU2005273638B2 (da)
BR (1)	BRPI0514420B1 (da)
CA (2)	CA2575058C (da)
CY (1)	CY1113684T1 (da)
DE (1)	DE602005023315D1 (da)
DK (2)	DK1778720T3 (da)
ES (1)	ES2613027T3 (da)
GB (1)	GB2431404A (da)
HK (1)	HK1105982A1 (da)
IL (2)	IL180727A (da)
MX (1)	MX2007002057A (da)
NO (1)	NO342832B1 (da)
NZ (2)	NZ584340A (da)
PL (1)	PL1778720T3 (da)
PT (2)	PT1778720E (da)
RU (1)	RU2396273C2 (da)
SG (3)	SG155211A1 (da)
SI (1)	SI1778720T1 (da)
WO (1)	WO2006018652A2 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1838331A4 (en)	2004-12-15	2012-12-26	Univ Colorado	ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF
AU2006327973B2 (en) *	2005-12-22	2012-04-12	Novabiotics Limited	Cyclic antimicrobial peptides
US9181303B2 (en)	2005-12-22	2015-11-10	Novabiotics Limited	Treatment of bacterial infections with cyclic antimicrobial peptides
AU2012203804B2 (en) *	2005-12-22	2014-10-16	Novabiotics Limited	Cyclic antimicrobial peptides
GB0702021D0 (en) *	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
GB0702022D0 (en) *	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
GB0702020D0 (en) *	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
EP2178549B1 (en) *	2007-07-26	2016-09-14	Revance Therapeutics, Inc.	Antimicrobial peptide and compositions thereof
US20100150985A1 (en) *	2008-04-24	2010-06-17	George Just	Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same
GB0817121D0 (en) *	2008-09-18	2008-10-29	Univ St Andrews	Anti-fungal therapy
CA2739842A1 (en) *	2008-10-06	2010-04-15	The Regents Of The University Of Colorado, A Body Corporate	Antimicrobial peptides and methods of use
DK2356135T3 (da) *	2008-11-05	2017-12-04	Wyeth Llc	Immunogen multikomponentsammensætning til forebyggelsen af beta-hæmolytisk streptokok (bhs) sygdom
US20100184684A1 (en)	2009-01-06	2010-07-22	C3 Jian, Inc.	Antibacterial and antifungal peptides
FR2941231B1 (fr)	2009-01-16	2016-04-01	Sederma Sa	Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
GB0905451D0 (en) *	2009-03-31	2009-05-13	Novabiotics Ltd	Biofilms
WO2010141760A2 (en) *	2009-06-05	2010-12-09	The Regents Of The University Of Colorado, A Body Corporate	Antimicrobial peptides
JP5664992B2 (ja) *	2009-08-26	2015-02-04	国立大学法人名古屋大学	細胞特異的ペプチド及びその用途
WO2011113604A1 (en) *	2010-03-17	2011-09-22	Universität Regensburg	Peptides or antibodies which bind to melanoma inhibitory activity (mia) protein
CN102206250B (zh)	2010-03-29	2017-03-15	翔升科技股份有限公司	低血球溶解性的抗微生物肽、药物组合物及其用途
GB201016733D0 (en)	2010-10-05	2010-11-17	Novabiotics Ltd	Compounds and their use
GB201021186D0 (en)	2010-12-14	2011-01-26	Novabiotics Ltd	Composition
RU2449805C1 (ru)	2011-01-27	2012-05-10	Общество С Ограниченной Ответственностью "Гармония"	Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
ES2679995T3 (es)	2011-03-11	2018-09-03	Vib Vzw	Moléculas y métodos para la inhibición y detección de proteínas
DE102011077071A1 (de) *	2011-06-07	2012-12-13	Beiersdorf Ag	Wirkstoffkombinationen aus Epsilon-Polylysin und Climbazol
KR101345333B1 (ko) *	2011-12-30	2013-12-30	조선대학교산학협력단	라이신 및 트립토판 잔기가 ４번 반복된 신규한 항균 및 항진균 펩타이드 및 이의 용도
GB201204457D0 (en) *	2012-03-14	2012-04-25	Novabiotics Ltd	Polypeptides and their use
WO2013142184A1 (en)	2012-03-19	2013-09-26	Yale University	Antimicrobial compositions and methods
KR102141254B1 (ko)	2012-03-23	2020-08-04	아미크로베, 인코포레이티드.	조직-적합성 특성을 갖는 항균물질의 조성물 및 용도
US20140120077A1 (en)	2012-10-28	2014-05-01	Revance Therapeutics, Inc.	Compositions and Methods for Safe Treatment of Rhinitis
US9662372B2 (en)	2013-02-20	2017-05-30	Biolog, Inc.	Compositions and methods to inactivate and/or reduce production of microbial toxins
RU2683651C2 (ru) *	2013-06-18	2019-04-01	Иван Дмитриевич Захаров	Лекарственное средство для лечения кератоконуса и других дегенеративных заболеваний роговицы и фармацевтические препараты на его основе
GB201409451D0 (en)	2014-05-28	2014-07-09	Ipabc Ltd	Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
US20170119814A1 (en) *	2014-06-17	2017-05-04	Albert Einstein College Of Medicine, Inc.	Therapeutic nanoparticles and methods thereof
US11484580B2 (en)	2014-07-18	2022-11-01	Revance Therapeutics, Inc.	Topical ocular preparation of botulinum toxin for use in ocular surface disease
GB201416727D0 (en) *	2014-09-22	2014-11-05	Novabiotics Ltd	Use
CN104311627B (zh) *	2014-10-29	2018-04-10	中山大学	一种抗菌肽的合成方法和应用
PL3106172T3 (pl) *	2015-06-15	2020-12-28	B. Braun Melsungen Ag	Środek aktywny przeciwdrobnoustrojowo i jego zastosowanie
US20210213096A1 (en) *	2016-02-19	2021-07-15	Forschungszentrum Borstel Leibniz-Zentrum Fur Medizin Und Biowssenschaften	Means and methods for treating bacterial infections
WO2018144545A1 (en)	2017-01-31	2018-08-09	Stc.Unm	Arginine-rich polypeptide compositions and methods of using same
US11285189B2 (en)	2017-04-06	2022-03-29	Amicrobe, Inc.	Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
US11931333B1 (en) *	2019-05-28	2024-03-19	Peter Van Horn	Topical treatment of herpes infections
CN112457375B (zh) *	2019-09-06	2022-12-02	韩苏	多肽化合物及其制备方法与应用
CN113264987B (zh) *	2021-05-31	2023-11-17	安徽农业大学	具有抗真菌和清除自由基活性的环色-苏-缬-异亮-亮肽及制备方法
CN113307848B (zh) *	2021-05-31	2023-11-17	安徽农业大学	具有抗真菌和清除自由基活性的环色-丝-缬-异亮-亮肽及制备方法
CN115669843A (zh) *	2022-10-26	2023-02-03	中国农业大学	一种采用高压微射流结合混合肽有效杀灭芽孢的方法
CN116332777A (zh) *	2023-02-20	2023-06-27	华中科技大学	二芳基苯甲胺类化合物、制备及作为载体合成多肽的应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3561444A (en)	1968-05-22	1971-02-09	Bio Logics Inc	Ultrasonic drug nebulizer
US3703173A (en)	1970-12-31	1972-11-21	Ted A Dixon	Nebulizer and tent assembly
US4051842A (en)	1975-09-15	1977-10-04	International Medical Corporation	Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de)	1976-06-11	1980-01-31	Siemens Ag, 1000 Berlin Und 8000 Muenchen	Implantierbare Dosiereinrichtung
EP0050271A1 (de)	1980-10-14	1982-04-28	Maschinenfabrik Rieter Ag	Automatische Auswechselvorrichtung von auslaufenden Vorgarnspulen für eine Spinnmaschine
US4383529A (en)	1980-11-03	1983-05-17	Wescor, Inc.	Iontophoretic electrode device, method and gel insert
US4635627A (en)	1984-09-13	1987-01-13	Riker Laboratories, Inc.	Apparatus and method
US4624251A (en)	1984-09-13	1986-11-25	Riker Laboratories, Inc.	Apparatus for administering a nebulized substance
US4962091A (en)	1986-05-23	1990-10-09	Syntex (U.S.A.) Inc.	Controlled release of macromolecular polypeptides
EP0400372B1 (de) *	1989-05-30	1995-08-02	Siemens Aktiengesellschaft	CMOS-ECL-Wandler
CA2061862A1 (en) *	1991-03-04	1992-09-05	Jonathan Duvick	Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms
JP3022615B2 (ja) *	1991-03-13	2000-03-21	日清製粉株式会社	ε−ポリリジンの製造方法
JP3000490B2 (ja) *	1991-04-08	2000-01-17	チッソ株式会社	抗白癬菌剤
US5486503A (en) *	1991-11-01	1996-01-23	The Trustees Of Boston University	Anti-fungal histatin-based peptides
EP0752885B1 (en)	1992-09-25	2003-07-09	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
JP3655359B2 (ja) *	1995-06-29	2005-06-02	株式会社サンコンタクトレンズ	含水性ソフトコンタクトレンズの洗浄および消毒用組成物
US5714577A (en) *	1996-01-26	1998-02-03	University Of Pittsburgh	Antimicrobial peptides
US6503881B2 (en) *	1996-08-21	2003-01-07	Micrologix Biotech Inc.	Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
JPH11113779A (ja) *	1997-10-14	1999-04-27	Asahi Chem Ind Co Ltd	除菌ウェットティッシュ
EA200101086A1 (ru) *	1999-04-15	2002-04-25	Эли Лилли Энд Компани	Антигрибковые агенты, выделенные из pseudomonas syringae
US20020001582A1 (en) *	1999-04-21	2002-01-03	Charter Edward A.	Methods and compositions for inhibiting microbial growth
JP2001264707A (ja) *	2000-03-22	2001-09-26	Chisso Corp	コンタクトレンズ用消毒保存用溶液
JP2002020320A (ja) *	2000-06-30	2002-01-23	Santen Pharmaceut Co Ltd	点眼液用防腐剤
FR2811666B1 (fr) *	2000-07-13	2005-04-01	Entomed S A	Peptides antifongiques et/ou antibacteriens, leurs preparations et les compositions les contenant
CN1336383A (zh) *	2000-07-29	2002-02-20	中国科学院昆明动物研究所	大蹼铃蟾抗菌肽及其制备方法和在制药中的应用
US7033991B2 (en) *	2001-07-16	2006-04-25	Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College	Inhibiting furin with polybasic peptides
EP1502949B1 (en) *	2002-04-25	2010-11-24	Toagosei Co., Ltd.	Antimicrobial polypeptide and utilization thereof
JP4461727B2 (ja) *	2003-07-18	2010-05-12	チッソ株式会社	外用剤組成物
US20080193616A1 (en) *	2007-02-13	2008-08-14	The Coca-Cola Company	Beverage compositions comprising polylysine and at least one weak acid

2005
- 2005-08-18 EP EP05778505A patent/EP1778720B1/en active Active
- 2005-08-18 PT PT05778505T patent/PT1778720E/pt unknown
- 2005-08-18 CN CN2005800281216A patent/CN101031583B/zh not_active Expired - Fee Related
- 2005-08-18 AU AU2005273638A patent/AU2005273638B2/en not_active Ceased
- 2005-08-18 CA CA2575058A patent/CA2575058C/en active Active
- 2005-08-18 EP EP08001112.5A patent/EP1927597B1/en not_active Not-in-force
- 2005-08-18 PL PL05778505T patent/PL1778720T3/pl unknown
- 2005-08-18 PT PT80011125T patent/PT1927597T/pt unknown
- 2005-08-18 CN CN2013101618914A patent/CN103360486A/zh active Pending
- 2005-08-18 DE DE602005023315T patent/DE602005023315D1/de active Active
- 2005-08-18 RU RU2007109518/04A patent/RU2396273C2/ru active
- 2005-08-18 SG SG200905379-4A patent/SG155211A1/en unknown
- 2005-08-18 CN CN2013101617432A patent/CN103360485A/zh active Pending
- 2005-08-18 AT AT05778505T patent/ATE479704T1/de active
- 2005-08-18 NZ NZ584340A patent/NZ584340A/en not_active IP Right Cessation
- 2005-08-18 SI SI200531161T patent/SI1778720T1/sl unknown
- 2005-08-18 DK DK05778505.7T patent/DK1778720T3/da active
- 2005-08-18 CA CA2974538A patent/CA2974538A1/en not_active Abandoned
- 2005-08-18 EP EP16176481.6A patent/EP3141559A1/en not_active Withdrawn
- 2005-08-18 EP EP09005438A patent/EP2096118A1/en not_active Withdrawn
- 2005-08-18 EP EP16179810.3A patent/EP3147293B1/en active Active
- 2005-08-18 WO PCT/GB2005/003245 patent/WO2006018652A2/en active Application Filing
- 2005-08-18 ES ES08001112.5T patent/ES2613027T3/es active Active
- 2005-08-18 JP JP2007526571A patent/JP5020078B2/ja active Active
- 2005-08-18 SG SG10201606278UA patent/SG10201606278UA/en unknown
- 2005-08-18 BR BRPI0514420-5A patent/BRPI0514420B1/pt active IP Right Grant
- 2005-08-18 MX MX2007002057A patent/MX2007002057A/es active IP Right Grant
- 2005-08-18 NZ NZ553494A patent/NZ553494A/en unknown
- 2005-08-18 DK DK08001112.5T patent/DK1927597T3/da active
- 2005-08-18 KR KR1020077003571A patent/KR101234780B1/ko active IP Right Grant
- 2005-08-18 US US11/573,770 patent/US7847059B2/en active Active
- 2005-08-18 SG SG2013007356A patent/SG188092A1/en unknown
2007
- 2007-01-16 IL IL180727A patent/IL180727A/en active IP Right Grant
- 2007-02-19 GB GB0703060A patent/GB2431404A/en not_active Withdrawn
- 2007-03-14 NO NO20071369A patent/NO342832B1/no unknown
- 2007-09-28 HK HK07110561.1A patent/HK1105982A1/xx unknown
2010
- 2010-09-29 US US12/893,663 patent/US8088888B2/en active Active
- 2010-11-30 CY CY20101101093T patent/CY1113684T1/el unknown
2011
- 2011-06-02 IL IL213319A patent/IL213319A/en not_active IP Right Cessation
- 2011-06-28 US US13/170,975 patent/US8350003B2/en not_active Expired - Fee Related
- 2011-11-30 US US13/308,479 patent/US8470769B2/en active Active

Also Published As

Publication number	Publication date
SG188092A1 (en)	2013-03-28
US20120071398A1 (en)	2012-03-22
SG10201606278UA (en)	2016-09-29
EP3147293B1 (en)	2022-05-04
NZ553494A (en)	2010-07-30
JP2008509980A (ja)	2008-04-03
CA2575058C (en)	2017-09-12
PL1778720T3 (pl)	2011-03-31
CN103360485A (zh)	2013-10-23
DE602005023315D1 (de)	2010-10-14
HK1105982A1 (en)	2008-02-29
NO342832B1 (no)	2018-08-13
EP1778720B1 (en)	2010-09-01
JP5020078B2 (ja)	2012-09-05
KR101234780B1 (ko)	2013-02-20
US8350003B2 (en)	2013-01-08
CY1113684T1 (el)	2016-06-22
BRPI0514420B1 (pt)	2022-05-17
PT1927597T (pt)	2017-02-10
US8088888B2 (en)	2012-01-03
US20070244044A1 (en)	2007-10-18
IL213319A0 (en)	2011-07-31
AU2005273638A1 (en)	2006-02-23
PT1778720E (pt)	2010-11-29
ATE479704T1 (de)	2010-09-15
IL180727A0 (en)	2007-06-03
WO2006018652A3 (en)	2006-07-13
AU2005273638B2 (en)	2011-09-29
CA2575058A1 (en)	2006-02-23
GB2431404A (en)	2007-04-25
US20110021415A1 (en)	2011-01-27
CN101031583A (zh)	2007-09-05
EP3141559A1 (en)	2017-03-15
US7847059B2 (en)	2010-12-07
RU2396273C2 (ru)	2010-08-10
EP1927597A1 (en)	2008-06-04
RU2007109518A (ru)	2008-09-27
NO20071369L (no)	2007-05-04
SI1778720T1 (sl)	2011-04-29
US20110269673A1 (en)	2011-11-03
ES2613027T3 (es)	2017-05-22
SG155211A1 (en)	2009-09-30
US8470769B2 (en)	2013-06-25
WO2006018652A2 (en)	2006-02-23
GB0703060D0 (en)	2007-03-28
DK1927597T3 (da)	2017-02-13
NZ584340A (en)	2010-09-30
EP1778720A2 (en)	2007-05-02
MX2007002057A (es)	2007-07-19
EP2096118A1 (en)	2009-09-02
KR20070083486A (ko)	2007-08-24
EP3147293A1 (en)	2017-03-29
BRPI0514420A (pt)	2008-06-10
CN101031583B (zh)	2013-06-05
CA2974538A1 (en)	2006-02-23
CN103360486A (zh)	2013-10-23
IL213319A (en)	2017-07-31
IL180727A (en)	2015-06-30
EP1927597B1 (en)	2016-11-02

Publication	Publication Date	Title
DK1778720T3 (da)	2010-11-29	Antimikrobielle peptider omfattende et arginin- og/eller lysinholdigt motiv
NZ595037A (en)	2013-07-26	Inhibition of biofilm organisms by combination of cysteamine and repetitive peptides
EA201170878A1 (ru)	2012-01-30	Полипептиды с ксиланазной активностью
BR0305426A (pt)	2004-08-24	Compostos inibidores de ns5b polimerase de hcv, bem como composição farmacêutica compreendendo os mesmos
DK1109831T3 (da)	2011-04-18	Cytotoksiske peptider modificeret ved store eller lipofile dele
DE602005020165D1 (de)	2010-05-06	Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
BR0306931A (pt)	2005-04-19	Peptìdeos como inibidores de protease serina-ns3 do vìrus da hepatite c
ATE483027T1 (de)	2010-10-15	Rekombinante n-glykosylierte proteine aus prokaryontischen zellen
HRP20140185T1 (hr)	2014-05-09	Peptidi i njihova primjena
EP2455462A3 (en)	2013-05-29	Lipase variants for pharmaceutical use
ATE254630T1 (de)	2003-12-15	Cyclosporine
WO2008052173A3 (en)	2008-11-13	Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
ATE465173T1 (de)	2010-05-15	Verändertes vp-1capsidprotein von parvovirus b19
WO2007068240A3 (de)	2008-04-10	Peptide für die wechselwirkung mit alpha-helikalen coiled-coil-strukturen und/oder coiled-coil-sequenzen, davon abgeleitete mittel und ihre verwendung
ATE506957T1 (de)	2011-05-15	Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
EP1930024A3 (en)	2008-08-06	G-CSF solution formulations having long-term stability
MY147920A (en)	2013-02-15	Antibacterial and antiviral peptides from actinomadura namibiensis
WO2008047370A3 (en)	2008-06-19	Compositions and methods for inducing angiogenesis
CY1111004T1 (el)	2015-06-11	Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
DE60126602D1 (de)	2007-03-29	Neue collectine
UA96564C2 (en)	2011-11-25	Peptide
HK1147210A1 (en)	2011-08-05	Anti-hypertensive agent
DE602007013796D1 (de)	2011-05-19	Ausstossflüssigkeit und ausstossverfahren
WO2004052916A3 (en)	2004-09-16	Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids
WO2003095482A3 (fr)	2004-04-08	Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens.